SPDR S&P Biotech ETF Sees Unusually Large Options Volume (NYSEARCA:XBI)

SPDR S&P Biotech ETF (NYSEARCA:XBI) was the target of some unusual options trading activity on Friday. Investors acquired 83,179 put options on the company. This is an increase of 50% compared to the average volume of 55,585 put options.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. AdvisorNet Financial Inc lifted its stake in SPDR S&P Biotech ETF by 7.3% during the third quarter. AdvisorNet Financial Inc now owns 1,463 shares of the exchange traded fund’s stock worth $147,000 after purchasing an additional 100 shares during the last quarter. Moors & Cabot Inc. lifted its position in SPDR S&P Biotech ETF by 3.8% in the 3rd quarter. Moors & Cabot Inc. now owns 2,717 shares of the exchange traded fund’s stock worth $272,000 after buying an additional 100 shares during the last quarter. Sequoia Financial Advisors LLC lifted its position in SPDR S&P Biotech ETF by 3.1% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 3,393 shares of the exchange traded fund’s stock worth $340,000 after buying an additional 101 shares during the last quarter. Kingsview Wealth Management LLC boosted its stake in SPDR S&P Biotech ETF by 1.8% in the third quarter. Kingsview Wealth Management LLC now owns 5,813 shares of the exchange traded fund’s stock worth $582,000 after buying an additional 103 shares in the last quarter. Finally, Investment Partners Asset Management Inc. grew its position in SPDR S&P Biotech ETF by 4.0% during the second quarter. Investment Partners Asset Management Inc. now owns 3,257 shares of the exchange traded fund’s stock valued at $270,000 after acquiring an additional 125 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

XBI stock opened at $123.43 on Friday. The firm has a 50 day simple moving average of $115.20 and a two-hundred day simple moving average of $98.71. The stock has a market cap of $7.49 billion, a PE ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $125.87.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.